89
17
Growth Score 89 in past quarter
7 pts
Heat Score 17 in past quarter
-71 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3818902
VINCE Labs develops and manufactures generic pharmaceutical formulations, peptide APIs, DNA kits and offers CRAMS services.
About the Company
VINCE Labs develops and manufactures generic pharmaceutical formulations, peptide active pharmaceutical ingredients, biotech products, and DNA collection kits. The company operates R&D and cGMP manufacturing facilities for APIs, intermediates, and finished dosage forms including tablets, capsules, oral liquids, injectables, and soft gelatin
capsules. VINCE Labs focuses on bio-generics, peptide synthesis, and custom synthesis projects. It also provides Custom Research and Manufacturing Services (CRAMS) for mid-sized and emerging biotech and pharmaceutical companies across the drug life cycle. Its portfolio spans multiple therapy areas such as anti-infectives, cardiovascular, oncology, gastro-intestinal, and central nervous system disorders.